Related by context. All words. (Click for frequent words.) 76 PSMA protein 70 neovasculature 69 CD# antigen 68 specific lectin receptors 67 CD# molecule 67 CD# receptor 67 ribonucleotide reductase clinically validated 67 somatostatin receptors 65 M2 subunit 65 epithelial cells lining 65 carcinoembryonic antigen 64 alpha folate receptor 64 polysaccharide polymer 64 androgen receptor AR 64 colorectal bladder 63 Epidermal Growth Factor Receptor 63 accumulate preferentially 63 TGF alpha 63 A3 adenosine receptor 63 hCG beta 63 MUC1 63 binds selectively 63 Factor Receptor 63 TTR gene 62 cell adhesion molecule 62 antigen CD# 62 HER2 HER2 62 receptor CXCR4 62 targets Galectin receptors 62 extracellular domain 62 HAAH 62 tumor antigen 62 fusion proteins 62 carbohydrate polymer 62 Alfacell proprietary ribonuclease 62 acid phosphatase PAP 62 NeoLipid R 62 synovial tissue 61 chemokine receptor 61 monoclonal antibody IgG1 Mab 61 HER2 ErbB2 61 c MYC 61 GPNMB 61 cancer immunotherapeutics 61 HER2 receptor 61 prostate cancer antigen prostatic 61 carcinoembryonic antigen CEA 61 HER1 61 surface glycoprotein 61 CCR9 60 sphingosine 1 60 cytokeratin 60 IAP inhibitor 60 antibody MT# 60 TRAIL Receptor 60 Vicinium TM 60 targeting CD# 60 NKG2D 60 PDGF receptor 60 intercellular adhesion molecule 60 CD# protein 60 Mucosal 60 IGF1R 60 EpCAM 60 SPINK1 60 lysophosphatidic acid LPA 60 selectively binds 60 vimentin 60 HER2 protein 60 humanized monoclonal antibody 60 protein tyrosine phosphatase 1B 60 metastatic colorectal 60 ERK1 2 60 luteinizing hormone releasing 60 mesothelin 59 chimeric monoclonal antibody 59 DLL4 59 nucleolin 59 tyrosine kinase receptor 59 induces apoptosis 59 CYP#A# CYP#D# 59 BiTE ® 59 colorectal gastric 59 Î ² 59 agonistic human 59 targeted radiotherapeutic 59 aberrantly activated 59 #T# tumor 59 cells overexpressing 59 huC# DM4 59 HER2/neu 59 receptor tyrosine kinase 59 E7 proteins 59 5alpha reductase 59 cathepsins 59 HER-2/neu 59 bispecific antibody 59 TIMP 59 Intravenous Human 59 EGFR protein 59 IGF IR 59 EGF receptor 59 Kinase Inhibitor 59 Aurora kinase 59 poly ADP ribose polymerase 59 tumor specific antigen 59 SGLT2 59 carcinoma HCC 59 Cytotoxic T 59 thromboxane A2 59 eIF 4E 59 serotonin 2C receptor 59 VSV G 59 humanized antibody 59 CYT# potent vascular disrupting 58 ovarian colon 58 IgG1 monoclonal antibody 58 recombinant adeno associated 58 EGFr 58 TRAIL receptors 58 monocytes macrophages 58 receptor CD# 58 NTDDS 58 interleukin IL -# 58 c Src 58 MAGE A3 58 Mesothelin 58 Upregulation 58 immunostimulatory 58 folate receptor 58 cytolytic 58 tumorigenicity 58 oral prodrug 58 selective kinase inhibitor 58 TNFa 58 ADAMTS# 58 glutamic acid decarboxylase 58 TrkA 58 Immunohistochemical analysis 58 VEGF receptor 58 VEGFR1 58 cytoprotective 58 mitogenic 58 irreversible inhibitor 58 essential thrombocythemia ET 58 colorectal carcinoma 58 E#F# 58 orally administered inhibitor 58 retinoic acid receptor 58 Proxinium TM 58 Trp p8 58 K ras mutations 58 VEGF induced 58 WT1 58 thyroid hormone receptor 57 constitutively active 57 XL# inhibits 57 inhibitor COX 57 TLR7 agonist 57 Exherin TM 57 L1 CAM 57 pathophysiological effects 57 Survivin 57 immunogen 57 receptor alpha 57 investigational immunotherapy 57 P selectin 57 monocyte chemoattractant protein 57 Enzastaurin 57 epithelial tumors 57 HER2 neu 57 humanized monoclonal antibodies 57 targeted antifolate 57 bispecific 57 survivin 57 colorectal adenocarcinoma 57 antiproliferative effects 57 PC3 cells 57 pancreatic prostate 57 selectively inhibited 57 adrenoceptor 57 N cadherin 57 CD# + [001] 57 receptors EGFR 57 NS5b 57 novel VDA molecule 57 constitutively expressed 57 TNFalpha 57 PSMA ADC 57 selective modulator 57 metaglidasen 57 MET amplification 57 B7 H4 57 dasatinib Sprycel ® 57 p# mitogen activated 56 telomerase reverse transcriptase 56 co stimulatory molecules 56 soluble tumor necrosis 56 Aflibercept 56 FSH receptor 56 activated lymphocytes 56 factor receptor EGFr 56 tumors GIST 56 AGTR1 56 CCR2 56 NPC 1C 56 iNOS 56 hormone LHRH antagonist 56 florbetaben 56 CDK cyclin dependent 56 LHRH receptors 56 TRAIL R2 56 ovarian endometrial 56 DAVANAT 56 immunohistochemical staining 56 metastatic carcinoma 56 c myc 56 CYC# 56 colorectal pancreatic 56 peptide antigens 56 DNA intercalator 56 ovarian breast 56 Dendreon investigational 56 hTERT 56 RAV# 56 ChR2 56 epithelial cell 56 metastatic pancreatic 56 breast pancreatic 56 EphA2 56 NS#/#A protease 56 OMP #M# 56 NY ESO 56 MCSP respectively 56 LHRH 56 plasmacytoid dendritic cells 56 Clusterin 56 Aplidin R 56 upregulates 56 Epstein Barr Virus EBV 56 EGFRvIII 56 colorectal ovarian 56 cyclooxygenase 56 GI mucosa resulting 56 cytotoxic T lymphocyte 56 MLL AF9 56 rabbit polyclonal 56 enkephalin 56 glucose transporter 56 novel therapeutic antibodies 56 annexin V 56 HER2 expression 56 mouse xenograft models 56 MKC# MT 56 HepG2 cells 55 vinorelbine tartrate 55 glycosylated 55 pan HDAC inhibitor 55 RRM1 55 anti CD3 55 generation antisense inhibitor 55 interferon γ 55 effector function 55 mediated inhibition 55 Cyclooxygenase 2 55 CD# expression [001] 55 Oncolytic 55 cervical breast 55 bladder ovarian 55 PNP inhibitor 55 extrahepatic 55 P#X# 55 hPAM4 55 castrate resistant prostate cancer 55 pDCs 55 TNFα 55 humanized anti 55 CEQ# 55 pancreatic lung 55 CCL# 55 inhibit EGFR 55 HGS ETR2 55 IMA# 55 neuroblastoma tumors 55 Carcinoid tumors 55 replicon 55 p# INK4a 55 aurora kinase 55 TRAIL receptor 55 Tumor Necrosis Factor 55 potently inhibit 55 aplastic anemia AA 55 MAGE A3 ASCI 55 oncoprotein 55 GSTP1 55 inhibit vascular endothelial 55 plasma kallikrein inhibitor 55 tumor xenografts 55 p#NTR 55 hENT1 55 Angiolix 55 vinca alkaloid 55 CEACAM1 55 C5aR 55 androgen independent 55 MGd 55 transfected 55 hCG Beta 55 IFN g 55 chemokine receptors 55 LHRH receptor positive 55 malignant ovarian 55 investigational monoclonal antibody 55 EGFr expressing metastatic colorectal 55 III EGFRvIII 55 Achieves Primary Endpoint 55 lymphoid organs 55 LymphoStat B belimumab 55 cytostatic 54 uPAR 54 IGF 1R 54 Factor VIIa 54 plasmid encoding 54 NKX#.# 54 progesterone receptor 54 hormone LHRH 54 receptor inhibiting monoclonal 54 Familial Adenomatous Polyposis FAP 54 novel immunotherapeutic 54 adenoviral 54 HSP# inhibitor 54 ALB # 54 potent cytotoxic 54 CTAP# Capsules 54 nucleoside analog 54 CDK inhibitor 54 EGFR HER2 54 Apaziquone 54 selectively inhibit 54 NS4A 54 NP2 54 tryptase 54 syngeneic 54 inhibitory receptor 54 NSCLC tumors 54 Trofex 54 iobenguane 54 gastric adenocarcinoma 54 antibody MAb 54 Her2 54 autocrine 54 Grb 2 54 ligand TRAIL 54 ErbB 54 ERalpha 54 intratumoral injection 54 thyroid peroxidase 54 SOX9 54 colon carcinoma 54 hyaluronidase enzyme 54 prostate carcinoma 54 non nucleoside inhibitor 54 potent inducers 54 GAP #B# 54 pancreatic ovarian 54 p# MAPK 54 IMC A# 54 Sapacitabine 54 Pralatrexate 54 skeletal metastases 54 relapsed leukemia 54 alveolar epithelial cells 54 FGFR2 54 whose tumors overexpress 54 hypermethylated 54 potently inhibited 54 Epidermal growth 54 pancreatic endocrine 54 HEK# cells 54 depsipeptide 54 Personalized Immunotherapy 54 sunitinib Sutent 54 metalloproteinase 54 DCVax R 54 basophils 54 tumor antigens 54 Lyn kinase 54 Irinotecan 54 nodal metastasis 54 mouse mammary tumor 54 CXCR4 receptor 54 MAGE A3 antigen 54 epithelial cancers 54 malignant ascites 54 FLT3 54 IL #R 54 adenocarcinomas 54 transmembrane receptor 54 radiotherapeutic 54 metastatic hormone refractory 54 systemic anaplastic large 54 Janus kinase 53 Elotuzumab 53 virulence determinants 53 CD4 receptor 53 precursor lesions 53 VALSTAR 53 caveolin 1 53 Granulocyte Colony Stimulating Factor 53 MAPK pathway 53 mutated BRAF gene 53 BRAF V#E mutation 53 Injectable Suspension 53 alvespimycin 53 viral antigens 53 IFN γ 53 envelope glycoprotein 53 metastatic neuroendocrine tumors 53 Luteinizing Hormone Releasing Hormone 53 untreated metastatic melanoma 53 lysyl oxidase 53 CXCL5 53 alpha2 53 potent inducer 53 mutated p# 53 OMP #R# 53 PEGylated anti 53 Panzem R NCD 53 human IgG1 monoclonal 53 ErbB3 53 IGFBP 3 53 CD#L 53 macrophage colony stimulating 53 BMP2 53 HDAC EGFR 53 ErbB2 53 humanized interleukin 6 53 MDR1 53 breast carcinomas 53 Serostim ® 53 recombinant fusion 53 gastrointestinal stromal tumors GISTs 53 mda 7 53 Ki# 53 p# antigen 53 castrate resistant 53 cyclin dependent kinase 53 Ankara MVA 53 vaginal candidiasis 53 downregulated 53 FK# 53 primary humoral immunodeficiency 53 cetuximab Erbitux R 53 chronic eosinophilic leukemia 53 Sudhir Agrawal D.Phil 53 tNOX 53 E selectin 53 Plasmid DNA 53 p#HER# 53 heparanase 53 brivanib 53 epithelial markers 53 COL#A# 53 somatostatin 53 alpha#beta# 53 Immunotherapeutic 53 activating mutations 53 RNAi therapeutic targeting 53 TNF α 53 oral ghrelin agonist 53 hCG β 53 metastatic bladder 53 IGFBP7 53 ALK inhibitor 53 CTGF 52 #I TM# 52 castration resistant prostate cancer 52 Degarelix 52 FasL 52 TGF β 52 albumin bound paclitaxel 52 anaplastic lymphoma kinase ALK 52 IDH mutations 52 Galectins 52 DGAT1 52 gastric carcinomas 52 LNCaP cells 52 metastatic gastric 52 fallopian tube cancers 52 thymidine kinase 52 myelodysplastic myeloproliferative diseases 52 Annamycin 52 folate receptors 52 cisplatin resistant 52 promoter methylation 52 glucocerebrosidase GCD 52 XYOTAX TM 52 Therapeutic Vaccine 52 microvascular endothelial cells 52 inducible nitric oxide synthase 52 Fibroblast 52 progesterone receptors 52 lymphoid malignancies 52 methionine aminopeptidase 52 papillary renal cell carcinoma 52 induces antibodies 52 PKCi 52 annexin 52 p# deficient 52 orthotopic model 52 oncolytic 52 systemically administered 52 metastatic colorectal carcinoma 52 interferon lambda 52 myeloperoxidase 52 T#I [002] 52 refractory chronic lymphocytic 52 castration resistant 52 HCV polymerase 52 Monocyte 52 IL 1ß 52 receptor tyrosine kinase inhibitor 52 radiation sensitizer 52 CD# [002] 52 glioma cells 52 HER2/neu protein 52 redox active 52 therapeutic monoclonal antibody 52 FOLFOX6 52 neoplastic cells 52 MyVax R 52 BRAF mutant 52 MAb 52 Pharmacokinetics PK 52 metastatic malignant 51 chemoresistant 51 virus AAV 51 PC# cells 51 BCR ABL protein 51 activin 51 SERMs 51 demonstrated antitumor activity 51 hepatoma 51 murine 51 CD#c 51 hA# 51 Adjuvant Treatment 51 signal transduction inhibitors 51 Aplidin 51 oncolytic virus therapies 51 lymphomas leukemias 51 liposomal doxorubicin 51 denileukin diftitox 51 cyclin E 51 Fibroblast Growth Factor Receptor 51 Melphalan 51 HCV replicon 51 aT cell 51 HER2 receptors 51 Bezielle 51 Antigenics QS 51 metastatic liver 51 glutamic acid decarboxylase GAD 51 granulosa cell 51 vidofludimus 51 anti PlGF 51 ovarian carcinoma 51 factor receptor EGFR 51 imatinib Gleevec ® 51 HyperAcute 51 microtubule inhibitor 51 cellular immunotherapy 51 cMET 51 ERa 51 FGFR1 51 Her2/neu 51 alkylating agent 51 GRNVAC1 51 LymphoStat B TM 51 busulfan 51 PAR1 51 CTAP# 51 CTL epitopes 51 IgG antibodies 51 TNF Blockers 51 LHRH antagonist 51 PKC# 51 CanAg 51 LHRH receptor 51 metastatic carcinoid 51 EGFR tyrosine kinase inhibitors 51 TOP2A 51 BCG refractory 51 inhibit replication 51 recurrent glioblastoma multiforme 51 BRAF mutation 51 ASONEP ™ 51 virus HCV protease inhibitor 51 Davanat 51 Leydig cells 51 Camptosar ® 51 ERBB2 51 MVA BN ® 51 hypereosinophilic syndrome 51 formerly LymphoStat B 51 RASSF1A 51 GVAX R 51 cell lymphoma CTCL 50 metastatic malignant melanoma 50 endoglin 50 S/GSK# 50 tissue transglutaminase 50 chemosensitizer 50 invasive lobular 50 XmAb ® 50 HuMax 50 myeloproliferative diseases 50 isotype 50 OncoVex 50 protein antigens 50 stage IIIb IV 50 cutaneous T 50 bendamustine HCl 50 PNT# 50 HGPIN 50 myeloma cells 50 recurrent ovarian 50 cytotoxic effects 50 HuLuc# 50 IgM antibodies 50 oligodendrocyte progenitor cells 50 IFN alpha 2a 50 Peginterferon alfa 2b 50 advanced pancreatic neuroendocrine 50 MVA MUC1 IL2 50 intraepithelial neoplasia 50 anti EGFR antibody 50 Intravenous CP 50 DNA hypermethylation 50 cervical lymph node 50 refractory multiple myeloma 50 polycythemia vera essential thrombocythemia 50 CYP#B# 50 refractory cutaneous T 50 IGFBP 50 SSc 50 BRCA deficient 50 NQO1 50 drug metabolizing enzymes 50 nonmetastatic 50 TNF blocker therapy 50 KRAS oncogene 50 renal fibrosis 50 compound AEZS 50 corticosteroid dexamethasone 50 pyruvate kinase 50 multiple myeloma MM 50 unresectable locally advanced 50 #beta 50 chemopreventive agent 50 MGMT gene 50 colorectal carcinomas 50 antifibrotic 50 pancreatic carcinoma 50 Insegia 49 serum biomarker 49 trastuzumab Herceptin ® 49 SOD1 gene 49 refractory metastatic 49 Vidaza azacitidine 49 alkylating agents 49 interferon IFN 49 plasmid DNA 49 Lymph node 49 metastatic cancers 49 Vandetanib 49 beta estradiol 49 KRAS mutated 49 endocrine therapies 49 p# mutation 49 paclitaxel cisplatin 49 OncoVEX GM CSF 49 DNA methylation biomarkers 49 Transgenic Mice 49 Gleevec resistant 49 TRO# 49 Modified Vaccinia Ankara 49 prostate cancer CaP 49 pT2 49 HBeAg negative 49 KRAS mutation 49 SNT-MC#/idebenone 49 HER2 positive metastatic breast 49 ALDH 49 hormone receptor negative 49 factor G CSF 49 prostate adenocarcinoma 49 fluoropyrimidine 49 renal cysts 49 radiolabeled TM# 49 factor TNF 49 idiopathic membranous nephropathy 49 cytomegalovirus CMV 49 MVA BN 49 metastatic GIST 49 adenoviral vectors 49 XIAP 49 CLL SLL 49 metastatic melanomas 49 lymphocytosis 49 KIF6 gene 49 neuroendocrine cancers 49 Aviptadil 49 chlamydial 49 node metastasis 49 metastatic prostate 49 Corgentin 49 Kinoid 49 Pim kinases 49 gastric carcinoma 49 EGFR inhibitors 49 TransVax ™ 49 HepaGam B 48 tumor lysate 48 antiangiogenic agent 48 pancreatic islet 48 GM CSF 48 sodium thiosulfate STS 48 serum antibody 48 mutated K ras 48 pmol L 48 estrogen receptor progesterone receptor 48 invasive carcinoma 48 Muraglitazar 48 refractory colorectal cancer 48 CD8 + cytotoxic 48 EGFR TK 48 T1c 48 ABCB1 48 goserelin 48 Ceflatonin 48 recurrent metastatic 48 gastrointestinal stromal tumor GIST 48 Her-2/neu 48 intranasal formulation 48 imatinib Gleevec 48 TLR9 agonist 48 pAkt 48 refractory gastrointestinal stromal 48 cytoreduction 48 GPC5 48 MAGE A3 protein 48 VP# [004] 48 bacterial biothreat agents 48 cytochrome P 48 HLA DQ2 48 Recombinant interferon alpha 48 HER2 amplified 48 thyroid carcinomas 48 SIR Spheres 48 Thiovir 48 diagnostic biomarker 48 alefacept 48 TNFR1 48 cervical intraepithelial neoplasia 48 azacytidine 48 Quinamed 48 inhibit metastasis 48 Zarnestra 48 GW# [003] 48 bovine thrombin 48 Epstein Barr virus EBV 48 refractory acute myeloid 48 p#INK#a 48 pediatric acute lymphoblastic 48 bevacizumab Avastin ® 48 mutant p# 48 factor receptor 48 GRN# 48 liver metastases 47 ALK inhibitors 47 intradermal injection 47 haematologic malignancies 47 HER2 amplification 47 KIT mutations 47 Th2 cytokines 47 HER2 overexpression 47 indolent follicular non 47 estrogen receptor ER 47 Balamuthia 47 2A/Furin technology 47 plasmid DNA pDNA 47 lentiviral vector 47 Amgen Neulasta R 47 cetuximab Erbitux ® 47 BioSante 2A/Furin technology 47 cholesteryl ester transfer 47 Aurexis 47 erlotinib Tarceva 47 Tarceva TM 47 Glioblastoma Multiforme 47 cetuximab Erbitux 47 leukemia AML 47 EGFR TKI 47 opioid induced constipation OIC 47 melanoma antigens 47 uterine ovarian 47 human chorionic gonadotropin hCG 47 osteopontin 47 cytopathic 47 hepatocellular carcinomas 47 Viread tenofovir disoproxil fumarate 47 alpha1 antitrypsin AAT deficiency 47 indinavir Crixivan 47 anthracycline chemotherapy 47 heterologous 47 V#F 47 adalimumab Humira 47 forodesine 47 Cloretazine R 47 nucleotide analog 47 RhD positive 47 TLR antagonist 47 Vaxfectin R formulated 46 neutralizing antibody 46 chronic myeloid 46 pancreatic adenocarcinoma 46 estrogen receptor 46 receptor CCR5 46 irinotecan oxaliplatin 46 UPLYSO 46 HIV reverse transcriptase 46 HER2/neu gene 46 Her2 positive 46 Cre recombinase 46 A1PI 46 receptor blocker 46 Paraplatin ® 46 KRAS mutant 46 EGFR activating mutations 46 Cloretazine 46 immunotherapeutic vaccine 46 oncogenic HPV 46 SPRYCEL ® 46 paclitaxel Taxol 46 subcutaneous immunoglobulin 46 RIP1 46 alpha fetoprotein AFP 46 ERCC1 46 sipuleucel T 46 receptor inhibitors 46 oropharyngeal candidiasis OPC 46 lentiviral vectors 46 metastatic renal cell 46 saline placebo 46 mutated KRAS gene 45 hepatitis C HCV 45 cis RA 45 progesterone receptor negative 45 therapy ERT 45 Clolar ® 45 KRAS mutations 45 mRCC 45 finasteride Proscar 45 coagulation disorders 45 cervical vulvar 45 K#R [002] 45 unresectable inoperable 45 superantigens 45 galiximab 45 malignant pleural mesothelioma 45 pentostatin 45 B CLL 45 recombinant interferon 45 T#I mutation 45 cancer mCRC 45 calcineurin inhibitor 45 advanced hepatocellular carcinoma 45 Human papillomavirus HPV 45 HBeAg positive patients 45 Alphanate R 45 IgM isotype 45 NRTI resistance 45 Nexavar sorafenib 45 HERCEPTIN 45 K ras 45 TroVax ® 44 ALT normalization 44 alemtuzumab Campath 44 Raptiva R 44 nilotinib Tasigna 44 e antigen HBeAg 44 Trastuzumab Herceptin 44 lipohypertrophy 44 gemtuzumab ozogamicin 44 Shc 44 Associated Diarrhea 44 mutated KRAS 44 nasal carriage 44 bladder carcinoma 44 EGFR mutations 44 hormone receptor positive 44 Raptiva ® 44 intranasal delivery 44 Dacogen decitabine 44 N. gonorrhoeae 44 oxysterols 44 adjuvant cisplatin 44 pretransplant 44 pamidronate 44 Alferon LDO 44 relapsing remitting MS RRMS 44 chronic HBV infection 43 antibody titer 43 angiotensin receptor 43 Beta hCG 43 PhG alpha 1 43 L asparaginase 43 EGFR mutation positive 43 Amgen Neulasta ® 43 Human papillomavirus 43 oblimersen 43 alfa 2a 43 interferon beta 43 nonnucleoside reverse transcriptase inhibitors 43 HER2 positive cancers 43 HIV coinfected 43 chlorambucil 43 HPV subtypes 43 HC2 test 43 HBsAg 43 Onrigin 43 anastrazole 43 oral squamous cell 43 Pafuramidine 43 basiliximab 43 ORENCIA R 43 Rituxan rituximab 43 anthracycline containing 42 anti idiotype 42 non mutated KRAS 42 predictive biomarker 42 Li Fraumeni 42 humoral responses 42 SCIg 42 aggressive systemic mastocytosis 42 lamivudine resistant 42 Pfizer Camptosar 42 MyVax ® 42 leukaemias 42 nelfinavir Viracept 42 mutant KRAS 42 seronegative 42 immunodeficiency disorders 42 refractory Hodgkin 41 HER2 negative 41 CsA 41 adefovir dipivoxil 41 Amigal 41 antiestrogen 41 HBeAg 41 ORENCIA ® 41 administered intranasally 41 GARDASIL ® 40 refractory gout 40 haematopoietic stem cell 40 cells multiply uncontrollably 40 deletion 5q 40 hepatitis C hepatitis B 40 tipranavir ritonavir 40 Toxoid 40 mCRC patients 40 systemic ALCL 39 neoadjuvant setting 39 transgenic rats 39 Theratope 39 pDNA vaccines 39 virus HBV 39 protease inhibitor PI 39 mcg dose 39 FOLFIRI alone 39 BARACLUDE ® 39 achieved sustained virological 39 complete cytogenetic response 38 CMV disease 38 immunodeficient 38 chlamydial infection 38 KRAS status 38 idiotype vaccines 38 human papilloma 38 intramuscular IM 38 MENOPUR ® 37 Pneumocystis carinii pneumonia 37 HBeAg negative patients 37 Transgenic mice 36 trivalent inactivated influenza 34 chronic HBV 33 acute myelogenous leukemia AML 32 Pentacel vaccine